2010: Spine Journal 10 (2010) Surgical treatment patterns among Medicare beneficiaries newly diagnosed with lumbar spinal stenosis
ChenTong2010SpineJ.pdf
Spine J 2010;10:588–594.
2012: Eye, Journal of The Royal College of Ophthalmologists; January 2012; Cost analysis comparing adjuvant epimacular brachytherapy with anti-VEGF monotherapy for the management of neovascular age-related macular degeneration. EMB combined with anti-VEGF
treatment has the potential to yield considerable cost savings, compared with anti-VEGF monotherapy.
EYE EMB UK cost analysis - FINAL.pdf
Eye, Journal of The Royal College of Ophthalmologists; (20 January 2012) | doi:10.1038/eye.2011.351
2012: Journal of American Heart Association; January 2012; November 3, 2011. The cost-effectiveness associated with continuous flow LVADs for destination therapy has improved significantly relative to the pulsatile flow devices. This change is explained by significant improvements in survival, functional status and reduction in implantation costs.
Rogers_Cost_Effectiveness_of_CF_LVADs_Circulation_HF_AIP.pdf
Journal of American Heart Association: Circ Heart Fail published January 2012, online November 3, 2011; DOI: 10.1161/CIRCHEARTFAILURE.111.962951
2011: Journal of Cardiac Surgery; August 18, 2011. A recent prospective, randomized controlled trial demonstrated that a continuous flow (CF) left ventricular assist device (LVAD) resulted in improved survival at 12 and 24 months compared to a pulsatile-flow (PF) device. The current study examines the hospitalization costs associated with treatment of New York Heart Failure Class IV patients when implanted with a CF LVAD and compares them to previously reported costs of a PF LVAD in the same population.
2011_Slaughter_et_al_Temporal_Changes_in_Hospital_Costs_for_Left_Ventricular_Assist_Device_Implantation.pdf
Clinical Ophthalmology: July 2011; Evaluation of economic efficiencies in clinical retina practice: activity-based cost analysis and modeling to determine impacts of changes in patient management.
The purpose of this study is to report the use of activity-based cost analysis to identify areas of practice efficiencies and inefficiencies within a large academic retinal center and a small single-specialty group.
2011 Clinical Ophthalmology
2011 ASCO Annual Meeting: Abstract "Trends in utilization of oncology drugs for Medicare fee-for-service beneficiaries from 2002 through 2009" is published as part of the 2011 Annual Meeting of the American Society of Clinical Oncology. The abstract is available on www.asco.org and Journal of Clinical Oncology
J Clin Oncol 29: 2011 (suppl; abstr e16625)
2011 Eye; Journal of The Royal College of Ophthalmologists: The Burden of Disease of Retinal Vein Occlusion: Review of the Literature RVO_Lit_Review_Laouri_2011_Eye.pdf
2010 American Journal of Managed Care: Cost-Effectiveness of 70-Gene MammaPrint Signature in Node-Negative Breast Cancer 2010 American Journal of Managed Care
2010: Retinal Physician: A Brave New World: The retina subspecialty is in the vanguard of changes to clinical practice and reimbursement 2010 Retinal Physician
2010: The American Journal of Orthopedics: Economic burden of plantar fasciitis treatment in the United States 2010 American Journal of Orthopedics
2010: American Journal of Respiratory and Critical Care Medicine: Sleep Apnea Testing and Outcomes in a Large Cohort of Medicare Beneficiaries with Newly Diagnosed Heart Failure 2010 American Journal of Respiratory and Critical Care
2010: Current Medical Research & Opinion: Burden of illness of diabetic macular edema: literature review 2010 Burden of Illness of Diabetic Macular Edema: Literature Review
2010: Journal of Clinical Oncology: Incidence and Clinical Complications of Myelodysplastic Syndromes among United States Medicare beneficiaries 2010__Incidence and Clinical Complications of Myelodysplastic Syndromes Among US Medicare Beneficiaries
2010: AACR-IASCL Poster Presentation 2010: AACR-IASCL Poster Presentation
2010_Poster at AACR-IASLC Joint Conference
2009: Costs & Rehabilitation Use of Stroke Survivors:A Retrospective Study of Medicare Beneficiaries
Top Stroke Rehabil. 2009 Sep-Oct;16(5):309-20.
2009_Costs and Rehabilitatation Use of Stroke Survivors
2009:Retinal Physician: Application of Financial Analysis to Three Retina Practices. June 2009
2009: 45th ASCO Annual Meeting Poster Presentation: Cost effectiveness of targeting chemotherapy with the 70-gene prognostic signature in early stage breast cancer patients. May 29-31, 2009, Orlando, Florida. ASCO Podcast
2009: International Journal of Infectious Diseases: The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups International Journal of Infectious Diseases. 2009 Jan;13(1):24-36
2008: American Society of Hematology Podium Presentation: Clinical and Economic Consequences of Myelodysplastic Syndromes in the United States: An Analysis of the Medicare Database
2008: American Heart Association Scientific Sessions:Podium Presentation: Resource Use and Costs of Heart Failure in Medicare Population, 2003-2005
2008: In Vitro Diagnostic Regulatory & Reimbursement Conference: Presentation: Evidence and Coverage as the True Pathway to Product Uptake Conference Website
2008: ABL Round Table Meeting: "How to Position for and Expedite Optimum Reimbursement and Coverage"
2008: Part B News:Four Steps to Boost Revenue with Clinical Trials
2008:Current Medical Research and Opinion: Economic Evaluation of Medication, Laser Trabeculoplasty, and Filtering Surgeries in Treating Patients with Glaucoma
2008:Clinical Therapeutics: Cost-Effectiveness Analysis of Antifungal Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation
2007:The Ninth International Symposium on Myelodysplastic Syndromes Poster Presentation: Prevalance of Cardiac Disease among a US Medicare Population with Myelodysplastic Syndromes & Incidence of Myelodysplastic Sydroms in the United States Medicare Population
2008:International Stroke Conference Poster Presentation:Costs and Rehabilitation of Stroke Patients: A Retrospective Study of Medicare Beneficiaries
2006:ICAAC Conference Poster Presentation:Hospital Costs of Esophageal Candidiasis, The Economic Impact of Esophageal Candidiasis within Hospital Expenditures across patient subgroups
2008:Current Medical Research and Opinion: The Impact of Esophageal Candidiasis on Hospital Charges and Costs Across Subgroups
2007:Breast Cancer Symposium Poster Presentation: HER-2 Testing and Trastuzumab Use in the Medicare Population
2007:Journal of Drugs in Dermatology, New Methods and Techniques: A Multiple-Domain Framework of Clinical, Economic, and Patient-Reported Outcomes for Evaluating Benefits of Intervention in Atopic Dermatitis
2006:Journal of Heart and Lung Transplantation: Hospital costs for left-ventricular assist devices for destination therapy, Lower costs for implantation in the post-REMATCH era
2006:ISHAM Poster Presentation:Cost-Effectiveness Analysis of Anti-Fungal Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation
2006:ASHP Poster Presentation:The Economic Impact of Aspergillosis: Analysis of Hospital Expenditures Across Patient Subgroups
2006:ASCO Poster Presentation:Incidence, Costs of Care, and Mortality of Medicare Beneficiaries Diagnosed with Cancer of Unknown Primary Origin
2005:ICAAC Poster Presentation:Cost Effectiveness Analysis of Combined Phenotype and Genotype Drug Resistance Testing versus Genotyping Alone
2005:NATCO Poster Presentation: Impact of Calcineurin Inhibitor on Side Effects and Mental Quality Of Life: Findings from The Patient Outcomes Registry For Transplant Effects On Life (PORTEL)
2005:PharmacoEconomics: The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis
2005:ISPOR Poster Presentation: Frequency of INR Testing in Medicare Beneficiaries at High Risk for Stroke
2005:ISHLT Poster Presentation:Advances in Patient and Economic Outcomes Associated with Left Ventricular Assist Devices for Destination Therapy
2004:ISHLT Poster Presentation:Lower costs associated with home discharge of bridge-to-transplant patients using the TLC-II portable driver
2004:ISHLT Poster Presentation: The Effect of a Heart Assist Device Clinical Study on Hospital Referrals and Revenues
2004:ISHLT Poster Presentation: Longitudinal analysis of quality of life in kidney and liver patients in the Patient Outcomes Registry for Transplant Effects on Life (PORTEL)
2004:ITNS Oral Presentation: Quality of life and side effect profile of liver versus kidney recipients the first two years posttransplant: findings from the Patient Outcomes Registry for Transplant Effect on Life (PORTEL)
2004:Journal of Investigative Dermatology: Look Beyond Financial Conflicts of Interest in Evaluating Industry-Academia Collaborations in Burden-of-Illness and Outcomes Research Studies in Dermatology.
2004:NATCO Oral Presentation: Quality of life and side effect profile of liver versus kidney recipients the first two years posttransplant: findings from the Patient Outcomes Registry for Transplant Effect on Life (PORTEL)
2003:Clinical Infectious Diseases: Amphotericin B-related Nephrotoxicity has an Economic Impact on Hospitals and Health Systems.
2003:Infectious Diseases Society of America Poster Presentation:The Economic Impact of Aspergillosis: Analysis of Hospital Expenditures and Payer Reimbursements
2003:International Transplant Nurses Society 12th Annual Symposium Oral Presentation:Quality of Life and Side Effects in Kidney Transplant Patients Treated with Cyclosporine- and Tacrolimus-based Immunosuppressive Regimens
2003:Transplant Immunosuppression Conference Oral Presentation:Side Effects and Quality of Life in a Cohort of Recent Kidney Transplant Recipients
2003:Pharmacoeconomics: Validation of Expert Opinion in Identifying Comorbidities Associated with Atopic Dermatitis/Eczema.
2003:Clinical Transplantation: The first report from the Patient Outcomes Registry for Transplant Effects on Life (PORTEL), Differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens
2003:Progress in Transplantation: The PORTEL Registry, Overview and Selected Findings
2003:Journal of the American Academy of Dermatology: Cost-Effectiveness Analysis of Tacrolimus Ointment Versus High-Potency Topical Corticosteroids in Adults with Moderate to Severe Atopic Dermatitis
2003:Biology of Blood and Marrow Transplantation: Pharmacoeconomics of Prophylaxis for Fungal Infections in Patients Undergoing a Hematopoietic Stem Cell Transplant
2003:British Journal of Dermatology: Prevalence of Hypertension Among Patients with Atopic Dermatitis
2002:American Heart Association Poster Presentation: Patterns and Outcomes of Care in the Emergency Treatment of Ischemic Stroke
2002:Journal of Medical Economics: Factors Associated with Increased Hospital Costs in Patients Treated with Lipid-based Amphotericin B for Empirical Therapy
2002:NATCO Poster Presentation: A Follow-up Report from the Patient Outcomes Registry for Transplant Effects on Life
2002:NATCO Oral Presentation: Predictors of Post-Transplant Quality of Life: A Follow-up Report from the Patient Outcomes Registry for Transplant Effects on Life
2002:Annales de Dermatologie et de Vénéréologie: Cost-Effectiveness Analysis of Tacrolimus Ointment and Topical Corticosteroids in Moderate to Severe Atopic Dermatitis.
2002:Quorum Consulting Newsletter: Reimbursement Capabilities
2002:American Transplant Congress Poster Presentation:Differences in Clinical Outcomes, Side Effects and Quality of Life in Patients Treated with Cyclosporine and Tacrolimus-based Immunosuppressive Regimens
2002:Journal of the American Academy of Dermatology: Cost of Atopic Dermatitis and Eczema in the United States
2002:Quorum Consulting Newsletter: Skin Conditions and New Treatments.
2001:Society for Investigative Dermatology Poster Presentation: Third-Party Payer Cost of Atopic Dermatitis and Eczema in the United States
2000:Journal of Clinical Oncology: Pharmacoeconomic Analysis of Liposomal Amphotericin B Versus Conventional Amphotericin B in the Empirical Treatment of Persistently Febrile Neutropenic Patients
Subscribe